Navigation Links
Implantable Defibrillators Lower Risk of Death in Older Heart Patients
Date:1/14/2009

American Heart Association rapid access journal report:

Study highlights:

-- Implantable cardioverter defibrillators (ICDs) may reduce the risk of death by 30 percent in patients with reduced heart function.

-- This survival benefit applied to patients 75 years and older in this primary prevention study.

-- Previous studies have focused on younger, healthier patients.

DALLAS, Jan. 14 /PRNewswire-USNewswire/ -- Implantable cardioverter defibrillators (ICDs) can improve survival in patients with heart damage --- even those in their 70s --- according to research reported in Circulation: Cardiovascular Quality and Outcomes.

Implanted ICDs reduced the risk of dying by 30 percent in patients younger than 65 years old, 65 to 74, and 75 and older, said Paul Chan, M.D., M.Sc., lead author of the study and assistant professor at the Mid-America Heart Institute and the University of Missouri in Kansas City.

Patients who have damaged heart muscle that results in diminished pumping action --- called left ventricular systolic dysfunction --- are candidates for ICDs to prevent death from life-threatening arrhythmias. The tiny devices are implanted under the skin and connected to the heart muscle by electrodes. An ICD automatically shocks the heart back into normal rhythm when the ICD detects life-threatening rhythms.

Previous studies of ICDs have been conducted in patients who are primarily younger than 75, and who have few complications such as diabetes, chronic obstructive lung disease or a history of stroke.

This primary prevention study recruited 986 consecutive patients who had diminished left ventricular function --- meaning the pumping chamber of the heart was functioning at no more than 35 percent of capacity. Patients were treated from March 2001 though June 2005 and followed through March 2007.

Researchers compared outcomes of 500 patients who received ICDs to those who didn't receive the devices. The median age of patients was 67. This was about seven years older than participants in an earlier study that investigated the use of ICDs in patients with heart failure (the SCD-HeFT trial) and about three years older than participants in a study that reported on the use of ICDs in patients who had heart attacks (the MADIT-2 trial).

Researchers said theirs was one of the first studies to examine whether the benefits of ICDs from controlled clinical trials apply to real-world patients. Their study was also the first to examine a clinically well-characterized primary prevention group with patients of both ischemic and non-ischemic causes of heart damage with more than three years of follow-up.

"We sought to determine the effectiveness of ICDs in real-world patients who are older and have multiple co-existing illnesses," Chan said.

Overall, 238 deaths occurred --- 130 (26.7 percent) in the non-ICD group and 108 (21.6 percent) in the ICD group. Of these, 116 were attributed to arrhythmia --- 67 (13.7 percent) in the non-ICD group and 49 (9.8 percent) in the ICD group.

"The ICD reduced all-cause mortality by 30 percent compared with patients who didn't receive ICDs," Chan said. "The use of ICDs in general practice reduced mortality similar to the levels seen in clinical trials. And, the use of ICDs in older patients and patients with comorbidities reduced mortality both in relative and absolute terms."

When researchers studied patients age 75 or older, they found that the level of survival benefit remained intact. But the benefit diminished when age was combined with multiple disease conditions.

The caveat, Chan said, was that "cost effectiveness estimates for ICD therapy in this study population depended upon both the degree and the number of comorbidities." Chan and his colleagues also reported in the paper cost-effectiveness estimates for the use of ICD therapy by age and comorbidity subgroups.

The study was limited because of the relatively few patients in their 80s. "I feel comfortable applying the findings to septuagenarians, but we continue to have limited data on ICD use among octogenarians," Chan said.

Co-authors are Brahmajee K. Nallamothu, M.D., M.P.H.; John A. Spertus, M.D., M.P.H.; Frederick A. Masoudi, M.D., M.S.P.H; Cheryl Bartone, B.S., M.P.H.; Dean J. Kereiakes, M.D.; and Theodore Chow, M.D. Individual author disclosures can be found on the manuscript.

Statements and conclusions of study authors that are published in American Heart Association scientific journals are solely those of the study authors and do not necessarily reflect the association's policy or position. The association makes no representation or guarantee as to their accuracy or reliability. The association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific association programs and events. The association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations are available at www.americanheart.org/corporatefunding.

NR09- 1000 (CV Quality and Outcomes/Chan)


'/>"/>
SOURCE American Heart Association
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. New Implantable Lenses Can Reduce the Need for Glasses After Cataract Surgery
2. Can Implantable Devices for Heart Failure Help Assess Risk of Future Adverse Events for Heart Failure Patients?
3. Nebivolol Lowers Blood Pressure in Mild-to-Moderate Hypertensive Patients as Demonstrated in a Study Published in the Journal of Clinical Hypertension
4. American Heart Association Comment Saving Lives in Type 2 Diabetics: Could It Be as Easy as Lowering Blood Pressure?
5. Risks Associated With Face Transplants May Be Lower Than Previously Thought, ASPS Journal Review Suggests
6. Nebivolol Lowers Blood Pressure in African Americans With Stage I-II Hypertension as Demonstrated in a Study Published in the Journal of Clinical Hypertension
7. UPDATE: Nebivolol Lowers Blood Pressure in African Americans With Stage I-II Hypertension as Demonstrated in a Study Published in the Journal of Clinical Hypertension
8. Retrospective Analysis Finds That Initiation of Insulin Glargine in Patients With Type 2 Diabetes was Associated With a Lower Incidence Rate of Myocardial Infarction as Compared With NPH Insulin
9. PNH Patients With Lower Levels of Hemolysis, Mild Anemia and Minimal Transfusion Support Have Significant Disease Burden; Soliris(R) Therapy Provided Clinical Improvements in PNH Patients Regardless of Disease Severity
10. OrbusNeichs Genous(TM) Bio-engineered R Stent(TM) has Lower MACE Rate than TAXUS(R) and CYPHER(R) Stents in Clinical Trial
11. Kmart Lowers Flu Shot Price to $10
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/12/2017)... Canada joint tech company Laughing Face has developed ... and features a powerful disinfection process. The company has ... and sanitizes women,s panties or babies, cloth diapers in 25 minutes. ... Laughing ... external water inlet. ...
(Date:5/10/2017)... 10, 2017 Radiology has become the number ... have also spiraled to the number one ranking as ... than ever before as the most complete and reliable ... with lower back pain an MRI may confirm a ... pain, resulting in entirely different treatment protocols.  In these ...
(Date:5/9/2017)... PORTLAND, Ore. , May 9, 2017 /PRNewswire/ ... company that provides technology solutions to improve the ... reported financial results for the first quarter ended ... that our products enable our customers to identify ... them to intervene before events like heart attacks ...
Breaking Medicine Technology:
(Date:5/26/2017)... , ... May 26, 2017 , ... ... announce a new educational seminar to focus on current legislative activity and the ... will begin at 1 p.m. Sunday, Sept. 10, and will continue through Monday, ...
(Date:5/26/2017)... ... May 26, 2017 , ... ... CareFusion NOX-T3 portable sleep monitor with its Somnoware Sleep Device Interface (SDI). Somnoware ... for diagnostic device operations. With this platform, initializing devices and importing studies are ...
(Date:5/26/2017)... ... 26, 2017 , ... Boar’s Head Brand®, one of the ... Day entertaining that are sure to satisfy your guests’ flavor cravings, while adding ... cheeses featured in these refreshingly balanced recipes are packed with flavor, creating the ...
(Date:5/26/2017)... ... May 26, 2017 , ... On May 24, the Congressional Budget Office ... U.S. House on May 4, would result in 23 million Americans losing their health ... the 2010 Patient Protection and Affordable Care Act (ACA). , “It is clear ...
(Date:5/26/2017)... ... May 26, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House ... focusing on the Peace Agreements being discussed by President Donald Trump and the rest ... to try to speed up peace talks in the continuous battle between Israel and ...
Breaking Medicine News(10 mins):